TheraSphere Japan Pre-Market Study
NCT: NCT07377487 · RECRUITING
NCT IDNCT07377487
StatusRECRUITING
Start Date2026-01-22
Completion2027-12-31
Brief Summary
To investigate the safety and effectiveness of BSJ019T in Japanese patients with primary or secondary liver who are not candidate for standard treatment.
Frequently Asked Questions
What is TheraSphere Japan Pre-Market Study?
TheraSphere Japan Pre-Market Study is a clinical trial registered under NCT07377487. Current status: RECRUITING.
What is the status of NCT07377487?
The current status of NCT07377487 (TheraSphere Japan Pre-Market Study) is: RECRUITING.
When did TheraSphere Japan Pre-Market Study start?
TheraSphere Japan Pre-Market Study started on 2026-01-22.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.